Quick answer
We found no trial of chaga and reishi together, and no official source names a problem with the pair. Each brings its own risk: chaga's oxalate has been linked to kidney damage after 3 months to 5 years of daily powder, and reishi is a possible rare cause of liver injury. Chaga has no benefit shown in people.1,2,3
Key facts
- At 14.2 g of oxalate per 100 g of powder, 3 g of chaga a day supplies about 420 mg of oxalate, more than a typical day's diet of 200 to 300 mg.1
- LiverTox gives the usual amount of reishi as 500 mg to 3 g a day and rates it a possible rare cause of liver injury.3
- Both grow on trees, and both are sold as powders, extracts and tea.2,3
- In a 2026 warning letter, FDA said a company's marketing of chaga and red reishi extracts with research on illness made them unapproved drugs.4
What is known about the pair
We found no trial that gave people both. Neither has an official source on medicine interactions either: LiverTox's reishi chapter names none, and LiverTox has no chapter on chaga. So the useful questions are about each mushroom's own risks, and those risks differ.3
Chaga (Inonotus obliquus) is a fungus that lives as a parasite on birch and other trees.2
Reishi is a large, reddish-brown mushroom with a fan-shaped cap that grows at the base of trees or on stumps. Because it is rare in the wild, it is cultivated on logs, sawdust or wood chips.3
In a March 2026 warning letter, the FDA found that a company had marketed its chaga extract, along with turkey tail and red reishi, by citing research on illness, which made them unapproved new drugs.4
What each has shown in people
Their evidence is uneven. We found no trial of chaga on its own in people, so no chaga benefit is graded. The only human studies we found tested an herb mixture that was 20% chaga, or blood cells in a dish. Reishi has one early finding, for a purified extract rather than the whole mushroom.5,6,7
A purified reishi beta-glucan may raise counts of some immune cells in healthy adults*7,8,9,10
Early evidence
In a randomized, placebo-controlled trial in healthy adults aged 18 to 55 (157 enrolled, 135 finished), 200 mg a day of a purified reishi beta-glucan for 12 weeks raised counts of several kinds of T cells and natural killer cells more than placebo. It did not measure whether people fell ill less often, and a company paid for it. A trial in young children who ate a yogurt with reishi beta-glucans found a similar rise. Whole reishi did not show this: 1.44 g a day for 4 weeks, and 4 g a day of an extract for 10 days, left immune measures unchanged in small trials.
Amount studied: 200 mg a day of purified reishi beta-glucan, for 12 weeks
LiverTox notes that none of reishi's claimed benefits has been demonstrated in adequately sized, properly controlled human trials.3
Chaga and reishi as tea
Water and alcohol extracts of chaga from Finland, Russia and Thailand all contained oxalic acid as their main organic acid, the most in a Russian water extract.11
Reishi has a distinctly bitter taste. It is used in cooking and to make herbal tea, but its main use has been in traditional Chinese medicine.3
None of the chaga sources we read measured the oxalate in a cup of chaga tea. Water extracts still had oxalic acid as their main organic acid, so brewing does not leave it behind.11
The two side by side
| Chaga | Reishi | |
|---|---|---|
| Benefit graded in people | None | Early, for a purified beta-glucan at 200 mg a day |
| Usual amount | No safe daily amount established | 500 mg to 3 g a day, per LiverTox |
| Main safety concern | Oxalate and kidney damage | Rare liver injury |
| When harm was reported | 3 to 15 g of powder a day, for 3 months to 5 years | Usually 1 to 2 months after starting |
| Our Mushroom Complex | Inside a shared blend of six mushrooms; chaga amount not given | 266 mg of extract from the fruiting body |
What's in ours
Our Mushroom Complex contains both. Its label gives reishi a row of its own and lists chaga as one of six mushrooms sharing a blend, without the chaga share, so we cannot say how much chaga a serving gives. We make no claim for either.
Kidney, liver and who should ask first
Oxalate nephropathy, kidney damage from oxalate crystals, has been reported in at least three people who took chaga powder every day for months or years.1,2,12
Chaga powders from three companies held 2.8 g, 11.2 g and 14.2 g of oxalate per 100 g.1
Rare cases of liver injury have been reported, usually 1 to 2 months after starting reishi, with tiredness, nausea, stomach pain, poor appetite, dark urine or yellowing of the skin and eyes. Most people recovered within 1 to 3 months of stopping, but one woman died.3
In two of the reported liver cases, the trouble began after the person switched to a powdered reishi product.3
One pattern runs through both: the reported harm involved powders. Every published case of kidney damage from chaga involved powder taken daily, and two of the reported reishi liver cases began after a switch to a powdered product.1,2,3,12
Two cautions overlap. Chaga lowered blood glucose in mice and a chaga peptide slowed platelets in laboratory tests, while laboratory and animal studies suggest reishi may lower blood sugar, and a trial in people found no change in clotting tests. These cautions rest on laboratory and animal work, not on cases in people.3,13,14,15
- Do not take chaga if you have kidney disease or have had kidney stones, unless your kidney doctor agrees1
- Ask first if you take vitamin C supplements: the man in one chaga kidney case also took 500 mg of vitamin C a day2
- Ask first if you have liver disease, and stop reishi if you notice dark urine, yellowing of the skin or eyes, or unusual tiredness3
- Ask first if you take insulin or another medicine that lowers blood sugar, or a blood thinner, or have surgery planned13,14
- Ask first if you are being treated for cancer, or are pregnant or breastfeeding
Questions people ask
What are the benefits of chaga and reishi?
Few have been shown. We found no trial of chaga on its own in people. Reishi has one early finding, a rise in some immune cells with a purified extract, and LiverTox says none of its claimed benefits has been shown in properly controlled trials.3,7
Can you drink chaga and reishi tea every day?
Daily chaga is where the reported harm lies: the published kidney cases involved daily powder for 3 months or longer, and no one has measured the oxalate in chaga tea. Reishi liver cases usually began 1 to 2 months after starting. Ask your doctor first, especially if you have kidney or liver problems.1,2,3
See what we make
Every product shows its whole label and what its lab report covers. The store opens soon.
Sources
- Lee S, Lee HY, Park Y, Ko EJ, Ban TH, Chung BH, Lee HS, Yang CW. Development of End Stage Renal Disease after Long-Term Ingestion of Chaga Mushroom: Case Report and Review of Literature. J Korean Med Sci. 2020;35(19):e122. Opened 2026-10-07.
- Kwon O, Kim Y, Paek JH, Park WY, Han S, Sin H, Jin K. Chaga mushroom-induced oxalate nephropathy that clinically manifested as nephrotic syndrome: A case report. Medicine (Baltimore). 2022;101(10):e28997. Opened 2026-10-07.
- LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Lingzhi, Reishi. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases. Last update October 5, 2024. Opened 2026-10-07.
- U.S. Food and Drug Administration. Warning letter, MARCS-CMS 720213, March 6, 2026. Opened 2026-10-07.
- Hong YH. Effects of the herb mixture, DTS20, on oxidative stress and plasma alcoholic metabolites after alcohol consumption in healthy young men. Integr Med Res. 2016;5(4):309-316. Opened 2026-10-07.
- Najafzadeh M, Reynolds PD, Baumgartner A, Jerwood D, Anderson D. Chaga mushroom extract inhibits oxidative DNA damage in lymphocytes of patients with inflammatory bowel disease. Biofactors. 2007;31(3-4):191-200. Opened 2026-10-07.
- Chen SN, Nan FH, Liu MW, Yang MF, Chang YC, Chen S. Evaluation of Immune Modulation by β-1,3; 1,6 D-Glucan Derived from Ganoderma lucidum in Healthy Adult Volunteers, A Randomized Controlled Trial. Foods. 2023;12(3):659. Opened 2026-10-07.
- Henao SLD, Urrego SA, Cano AM, Higuita EA. Randomized Clinical Trial for the Evaluation of Immune Modulation by Yogurt Enriched with β-Glucans from Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Agaricomycetes), in Children from Medellin, Colombia. Int J Med Mushrooms. 2018;20(8):705-716. Opened 2026-10-07.
- Wachtel-Galor S, Tomlinson B, Benzie IF. Ganoderma lucidum ("Lingzhi"), a Chinese medicinal mushroom: biomarker responses in a controlled human supplementation study. Br J Nutr. 2004;91(2):263-269. Opened 2026-10-07.
- Wicks SM, Tong R, Wang CZ, O'Connor M, Karrison T, Li S, Moss J, Yuan CS. Safety and tolerability of Ganoderma lucidum in healthy subjects: a double-blind randomized placebo-controlled trial. Am J Chin Med. 2007;35(3):407-414. Opened 2026-10-07.
- Glamočlija J, Ćirić A, Nikolić M, Fernandes Â, Barros L, Calhelha RC, Ferreira IC, Soković M, van Griensven LJ. Chemical characterization and biological activity of Chaga (Inonotus obliquus), a medicinal "mushroom". J Ethnopharmacol. 2015;162:323-332. Opened 2026-10-07.
- Kikuchi Y, Seta K, Ogawa Y, Takayama T, Nagata M, Taguchi T, Yahata K. Chaga mushroom-induced oxalate nephropathy. Clin Nephrol. 2014;81(6):440-444. Opened 2026-10-07.
- Wang J, Wang C, Li S, Li W, Yuan G, Pan Y, Chen H. Anti-diabetic effects of Inonotus obliquus polysaccharides in streptozotocin-induced type 2 diabetic mice and potential mechanism via PI3K-Akt signal pathway. Biomed Pharmacother. 2017;95:1669-1677. Opened 2026-10-07.
- Hyun KW, Jeong SC, Lee DH, Park JS, Lee JS. Isolation and characterization of a novel platelet aggregation inhibitory peptide from the medicinal mushroom, Inonotus obliquus. Peptides. 2006;27(6):1173-1178. Opened 2026-10-07.
- Kwok Y, Ng KFJ, Li CCF, Lam CCK, Man RYK. A prospective, randomized, double-blind, placebo-controlled study of the platelet and global hemostatic effects of Ganoderma lucidum (Ling-Zhi) in healthy volunteers. Anesth Analg. 2005;101(2):423-426. Opened 2026-10-07.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
This page is information, not medical advice. Talk to your doctor or pharmacist about your own situation.